FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $238,778,000 | +1251.5% | 6,338,678 | +510.3% | 8.95% | +1188.1% |
| Q4 2020 | $17,668,000 | -53.1% | 1,038,678 | -87.0% | 0.70% | -66.1% |
| Q3 2020 | $37,644,000 | -22.7% | 8,009,353 | +0.3% | 2.05% | -31.8% |
| Q2 2020 | $48,727,000 | +175.8% | 7,988,053 | +2.6% | 3.00% | +82.4% |
| Q1 2020 | $17,667,000 | -50.5% | 7,783,001 | 0.0% | 1.65% | -39.2% |
| Q4 2019 | $35,724,000 | +144.9% | 7,783,001 | +106.7% | 2.71% | +76.6% |
| Q3 2019 | $14,590,000 | -19.4% | 3,765,168 | +25.4% | 1.53% | -22.5% |
| Q2 2019 | $18,110,000 | -55.9% | 3,003,342 | -2.0% | 1.98% | -57.0% |
| Q1 2019 | $41,062,000 | +58.7% | 3,064,346 | +10.2% | 4.60% | +36.0% |
| Q4 2018 | $25,867,000 | -45.0% | 2,781,346 | -17.7% | 3.38% | -18.3% |
| Q3 2018 | $47,065,000 | +163.5% | 3,381,117 | +199.3% | 4.14% | +137.3% |
| Q2 2018 | $17,862,000 | +43.5% | 1,129,761 | +276.6% | 1.74% | -17.9% |
| Q4 2015 | $12,450,000 | +108.3% | 300,000 | +24.7% | 2.12% | +101.1% |
| Q2 2015 | $5,976,000 | -48.0% | 240,597 | -52.2% | 1.06% | -56.1% |
| Q1 2015 | $11,490,000 | -48.5% | 502,832 | -39.1% | 2.40% | -44.6% |
| Q4 2014 | $22,311,000 | +30.1% | 826,332 | -43.5% | 4.34% | +21.9% |
| Q3 2014 | $17,148,000 | -12.0% | 1,461,900 | +16.7% | 3.56% | +15.5% |
| Q2 2014 | $19,484,000 | -12.8% | 1,253,000 | +10.3% | 3.08% | -11.0% |
| Q1 2014 | $22,334,000 | +188.6% | 1,136,000 | +146.4% | 3.46% | +155.7% |
| Q4 2013 | $7,740,000 | – | 461,000 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|